HealthLynked Corp Annual Report - How They Did This Year

I’m breaking down HealthLynked Corp’s performance to help you understand their current situation. My goal is to translate complex filings into plain English so you can decide if this company fits your investment goals.

1. What does this company do?

HealthLynked is shifting from a traditional healthcare provider to a "software-first" business. They are selling their physical clinics to focus on two areas:

• Digital Healthcare: A cloud platform for medical records and 24/7 telemedicine. This brings in subscription fees, though it currently accounts for less than 10% of total revenue.
• Medical Distribution: An online store (MedOfficeDirect) that sells medical supplies. This is their main business, generating over 90% of their $2.07 million in annual revenue.

2. Financial Health: Still in "Survival Mode"

The company is in a precarious spot. While they lost less money than last year, they are still burning through cash. They rely entirely on their CEO, Dr. Michael Dent, to keep the lights on.

• Revenue is Dropping: Revenue fell 31% to $2.07 million as they exited the physical clinic business.
• The "Going Concern" Warning: Auditors doubt the company can stay in business. They lack the cash to cover their $5.37 million in annual operating expenses.
• Cash Crunch: As of December 31, 2025, they had only $37,136 in the bank. This provides less than one month of operating cash.
• The Debt Trap: The CEO keeps the company alive with loans. In early 2026, they combined these into a $5.7 million loan. It carries a 12% interest rate and matures in 2029. The company cannot afford the $684,000 in annual interest payments.

3. Major Wins and Challenges

• Cost Cutting: The company cut its annual loss from $6.1 million to $3.3 million by selling underperforming clinics.
• Leadership Shakeup: Three different people have served as CFO since early 2024, causing instability. They hired a new COO, Duncan McGillivray, in late 2025 to manage the digital transition.
• The "1-for-100" Reverse Split: In September 2025, they combined every 100 shares into one to boost the share price and stay listed on the OTC markets.
• Supplier Risk: Their online store is fragile. A single supplier provides 98% of their products. If that relationship ends, their main revenue source could vanish.
• Internal Control Issues: Management admits their record-keeping is ineffective. They lack written financial policies, which increases the risk of accounting errors.
• Governance Concerns: Dr. Dent failed to file required ownership reports on time twice in 2025, which can lead to SEC scrutiny.

4. Key Risks: The "Minefield"

• The "Dent" Factor: The company relies on the CEO for survival. If he stops providing capital, the company would likely face immediate insolvency.
• Dilution Risk: The CEO’s $5.7 million loan is "convertible." He can turn that debt into new shares at any time. This creates more shares, which reduces your ownership percentage and the value of your investment.
• Legal Protections: The company must pay for the legal defense of its officers if they are sued. This could drain cash during a crisis.

5. Future Outlook

Management is in a "make or break" period. They are leaner, but much smaller. Their future depends on scaling their digital platform before they run out of cash. Given the tiny cash balance and heavy reliance on the CEO, this remains a high-risk situation.

Bottom Line for Investors: HealthLynked is currently a speculative play. The company is essentially operating on a month-to-month basis, sustained only by the financial support of its CEO. Before considering an investment, ask yourself if you are comfortable with the high probability of share dilution and the significant risk that the company may not be able to sustain its operations without further capital injections.